Gain Therapeutics, Inc. announced that Matthias Alder has departed the Company in order to pursue other opportunities. Upon Mr. Alder?s departure, the Company appointed Gene Mack, the Company?s current Chief Financial Officer, as interim Chief Executive Officer, effective June 25, 2024. Mr. Mack will retain his role as Chief Financial Officer.

Khalid Islam, Ph.D., founder and Chairman of the Company?s Board of Directors, will bolster management as Executive Chairman until a permanent CEO is appointed.